Department of Ophthalmology

Medicine & Life Sciences

1. Eye 100%
2. Indonesia 77%
3. Uveitis 40%
4. Visual Acuity 35%
5. Ocular Tuberculosis 35%
6. Blindness 27%
7. Intraocular Pressure 25%
8. Retinoblastoma 24%
9. Glaucoma 22%
10. Cataract 22%
11. Ocular Vision 22%
12. Corneal Ulcer 20%
13. Vision Disorders 19%
14. Eye Diseases 19%
15. Leprosy 17%
16. Myopia 16%
17. Cornea 16%
18. Systematic Reviews 16%
19. Therapeutics 14%
20. Tuberculosis 14%
21. Aldehyde Dehydrogenase 14%
22. Meta-Analysis 14%
23. Amnion 13%
24. Rabbits 13%
25. Inflammation 13%
26. Tears 13%
27. Bevacizumab 13%
28. Lasers 12%
29. Eyelids 12%
30. Ocular Toxoplasmosis 11%
31. Diabetic Retinopathy 11%
32. Light Coagulation 11%
33. Laser In Situ Keratomileusis 11%
34. Phacoemulsification 11%
35. Ophthalmic Solutions 11%
36. Vitrectomy 11%
37. Pterygium 11%
38. Cytomegalovirus 10%
39. Wounds and Injuries 10%
40. Exophthalmos 10%
41. Dry Eye Syndromes 10%
42. Ophthalmologists 10%
43. Panuveitis 10%
44. Keratitis 9%
45. Neovascular Glaucoma 9%
46. HIV 9%
47. Neoplasms 9%
48. Gold 9%
49. Aqueous Humor 9%
50. Ganglia 9%
51. Transplants 9%
52. Retina 9%
53. Anterior Uveitis 8%
54. Transplantation 8%
55. Voriconazole 8%
56. Retinopathy of Prematurity 8%
57. Income 8%
58. Optic Nerve Diseases 8%
59. Eye Manifestations 8%
60. Child 8%
61. Optic Nerve 8%
62. Developing Countries 8%
63. Trabeculectomy 7%
64. Polymerase Chain Reaction 7%
65. Paracentesis 7%
66. Glaucoma Drainage Implants 7%
67. Anterior Chamber 7%
68. Retinal Vasculitis 6%
69. Cytidine Diphosphate Choline 6%
70. Global Burden of Disease 6%
71. Incidence 6%
72. Retrospective Studies 6%
73. Angle Closure Glaucoma 6%
74. Guidelines 6%
75. Ophthalmology 6%
76. Nose 6%
77. Eye Injuries 6%
78. Graves Ophthalmopathy 6%
79. Drainage 6%
80. Infections 6%
81. Lacrimal Duct Obstruction 6%
82. Stevens-Johnson Syndrome 5%
83. Ethambutol 5%
84. Endophthalmitis 5%
85. Refractive Errors 5%
86. Consensus 5%
87. Choroiditis 5%
88. Randomized Controlled Trials 5%
89. Injections 5%
90. Optical Coherence Tomography 5%
91. Diplopia 5%
92. Interferon Type I 5%
93. Cohort Studies 5%
94. beta-Thalassemia 5%
95. Quality of Life 5%
96. Cross-Sectional Studies 5%
97. Pediatrics 5%
98. Premature Infants 5%
99. Eye Abnormalities 5%